Pharma Journalist 8778 posts 0 comments

Telix announces it has entered into an agreement to acquire IsoTherapeutics Group, LLC (IsoTherapeutics), a specialty radiopharmaceutical development and bioconjugation firm, based in…
Read More...

Bristol Myers Squibb announced that it has successfully completed its acquisition of RayzeBio, Inc. With the completion of the acquisition, RayzeBio shares have ceased trading on the…
Read More...

Amneal Pharmaceuticals, Inc. announced that it has entered into an exclusive licensing agreement with Zambon Biotech SA, part of the Zambon group, for IPX203 in the European Union,…
Read More...

Bayer announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for BAY 2927088 for the treatment of adult patients with unresectable or…
Read More...

AstraZeneca announced the successful completion of the acquisition of Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company developing innovative cell…
Read More...

Immunocore Holdings plc, a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with…
Read More...

AbbVie Inc. and Tentarix Biotherapeutics announced a multi-year collaboration focused on the discovery and development of conditionally-active, multi-specific biologic candidates in…
Read More...

Ligand Pharmaceuticals Incorporated announced that its partner Eisai Co., Ltd. obtained marketing authorization approval in January 2024 from the Japanese Ministry of Health, Labour and…
Read More...

WuXi Advanced Therapies, a wholly owned subsidiary of WuXi AppTec, announced that the U.S. Food and Drug Administration (FDA) has approved its Philadelphia site to begin the analytical…
Read More...

Charles River Laboratories International, Inc. announced a strategic agreement with Wheeler Bio, Inc., an antibody contract development and manufacturing organization (CDMO) focused on…
Read More...